DENDRITIC CELLS: The Master Antigen-Presenting Cells Linking Innate and Adaptive Immunity
Dendritic cells are the most powerful antigen-presenting cells (APCs) in the immune system. Their primary function is to detect pathogens, capture antigens and activate naïve T cells, making them essential for triggering adaptive immune responses. Positioned at the body’s major interfaces with the environment, dendritic cells act as sentinels that continuously monitor for danger. Once they detect a threat, they undergo a remarkable transformation that enables them to migrate to lymph nodes and teach T cells what to attack. Without dendritic cells, the adaptive immune system would not activate effectively.
What You Need to Know
Dendritic cells are specialised immune cells that act as the primary link between innate immune detection and adaptive immune activation. They arise from bone marrow precursors and populate tissues that are regularly exposed to the external environment, including the skin, respiratory tract, gastrointestinal tract, and secondary lymphoid organs. In their immature state, dendritic cells are optimised for antigen capture, using processes such as phagocytosis, the engulfment of large particles, macropinocytosis, the non-specific uptake of surrounding fluid, and receptor-mediated uptake that targets specific molecular patterns.
Several features distinguish dendritic cells from other antigen-presenting cells and explain their central role in immune coordination:
High efficiency at capturing and processing antigens in peripheral tissues
Expression of pattern recognition receptors that detect PAMPs and DAMPs, molecular signals of infection or tissue damage
Capacity to migrate from tissues to lymph nodes once activated
When dendritic cells encounter PAMPs or DAMPs through their pattern recognition receptors, they undergo a maturation process that fundamentally changes their function. Antigen uptake is reduced, while expression of costimulatory molecules and MHC molecules is increased, preparing the cell for interaction with T lymphocytes. Mature dendritic cells then migrate to regional lymph nodes, where they present processed antigen to naïve T cells and provide the additional signals required for T cell activation. Through this process, dendritic cells determine when adaptive immunity is initiated and shape the nature of the immune response that follows.
Beyond the Basics
Immature and Mature Dendritic Cells
Dendritic cells exist in functionally distinct immature and mature states, each suited to a specific role in immune surveillance and activation. Immature dendritic cells are found in peripheral tissues where exposure to pathogens is likely, such as the skin and mucosal surfaces. In this state, they are highly efficient at antigen capture and processing but deliberately poor at activating T cells. This separation of function helps prevent unnecessary immune activation in response to harmless environmental antigens.
When immature dendritic cells detect danger signals through pattern recognition receptors, including Toll-like receptors and NOD-like receptors, they undergo a coordinated maturation process. During maturation, their focus shifts away from antigen uptake and toward antigen presentation and immune instruction. This transition involves:
Reduced phagocytic activity, as antigen capture is no longer the priority
Increased surface expression of MHC class I and class II molecules
Upregulation of costimulatory molecules such as CD80 and CD86
Production of cytokines that influence downstream T cell responses
Following maturation, dendritic cells migrate to regional lymph nodes, where their primary role becomes interaction with naïve T cells.
Antigen Processing and Presentation
Dendritic cells process antigens and present them to T cells using two major pathways. Antigens derived from extracellular sources are presented on MHC class II molecules to CD4⁺ T helper cells, supporting helper and regulatory immune functions. Antigens originating from within the cell are presented on MHC class I molecules to CD8⁺ cytotoxic T cells, enabling targeted killing of infected or malignant cells.
A defining feature of dendritic cells is their ability to perform cross-presentation, a process in which extracellular antigens are presented on MHC class I molecules. This mechanism allows cytotoxic T cell responses to be initiated against viruses or tumour antigens that do not directly infect dendritic cells. Without cross-presentation, effective CD8⁺ T cell responses to many intracellular threats would be severely limited.
Interaction With T Cells in the Lymph Node
Within lymph nodes, dendritic cells orchestrate T cell activation through the delivery of three essential signals. The first signal is antigen presentation via MHC molecules, which provides specificity. The second signal is costimulation, delivered through molecules such as CD80 and CD86, ensuring that T cell activation occurs only in the presence of genuine danger. The third signal consists of cytokines that guide T cell differentiation.
The cytokine environment created by dendritic cells directs naïve T cells toward specific functional pathways, including Th1, Th2, Th17, or regulatory T cell lineages. This layered control allows immune responses to be tailored to the nature of the threat while limiting inappropriate or excessive activation.
Specialised Dendritic Cell Subsets
Dendritic cells are not a uniform population, and several specialised subsets perform distinct immunological functions. Langerhans cells reside in the epidermis and form an early defensive barrier against pathogens that breach the skin. Conventional dendritic cells are divided into cDC1 and cDC2 subsets, with cDC1 cells particularly efficient at cross-presentation and cDC2 cells more involved in helper T cell activation.
Plasmacytoid dendritic cells represent a functionally distinct subset with a major role in antiviral defence. These cells produce large quantities of type I interferons in response to viral nucleic acids, contributing to early containment of viral infection and amplification of antiviral immune responses.
Coordination With Other Immune Cells
Dendritic cells communicate extensively with other immune cells, including natural killer cells, B cells, and macrophages. Through cytokine secretion and cell-to-cell interactions, they help shape the broader immune environment rather than acting in isolation.
For example, interleukin-12 produced by dendritic cells enhances natural killer cell cytotoxicity and promotes differentiation of T cells toward a Th1 phenotype, which supports defence against intracellular pathogens. These interactions place dendritic cells at the centre of immune coordination, linking innate detection to adaptive response while integrating signals from multiple immune cell populations.
Clinical Connections
Dendritic cell function is critical for effective immune defence, and disruption at any stage can have wide clinical consequences. Impaired antigen capture, defective maturation, or inadequate costimulatory signalling can limit T cell activation, leading to chronic or recurrent infections and reduced vaccine efficacy. In these settings, antigens may be presented without sufficient immune instruction, resulting in weak or short-lived adaptive responses despite repeated exposure.
Several disease patterns highlight the clinical impact of altered dendritic cell activity:
Chronic infections associated with impaired antigen presentation and T cell priming
Reduced vaccine responses due to inadequate dendritic cell maturation or migration
Autoimmune disease linked to inappropriate presentation of self-antigens with costimulatory signals
Tumour immune evasion through suppression of dendritic cell activation and function
In autoimmune conditions, dendritic cells can contribute to loss of immune tolerance by presenting self-antigens in an inflammatory context. When costimulatory molecules and pro-inflammatory cytokines are expressed alongside self-derived peptides, autoreactive T cells may become activated rather than suppressed. This mechanism is implicated in diseases such as rheumatoid arthritis and systemic lupus erythematosus, where dendritic cell driven T cell activation sustains chronic inflammation.
Dendritic cells are also central to modern immunotherapy strategies. Cancer cells frequently inhibit dendritic cell maturation or antigen presentation, limiting effective antitumour T cell responses. Therapeutic approaches aim to overcome this suppression by enhancing dendritic cell activation, loading dendritic cells with tumour antigens, or using adjuvants that stimulate pattern recognition receptors. These strategies explain cancer vaccines and emerging personalised therapies, where directing dendritic cell mediated T cell responses is key to improving immune control of disease.
Concept Check
Why are dendritic cells considered the key link between innate and adaptive immunity?
What changes occur when dendritic cells mature after encountering a pathogen?
What is cross-presentation, and why is it important?
How do dendritic cells activate naïve T cells in lymph nodes?
What are plasmacytoid dendritic cells best known for?